BD Advances Iliac Artery Treatment Across the European Union
FRANKLIN LAKES, N.J., March 5, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking for the Revello™ Vascular Covered
